Longitudinal study on glycaemic control and quality of life in patients with Type 2 diabetes mellitus referred for intensified control

Patricia P M Goddijn, H. J G Bilo, E. J M Feskens, K. H. Groenier, K.I. Van der Zee, B. Meyboom-De Jong

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Aim: The aim of our study was to describe investigate and association between improved glycaemic control on quality of life(QoL) during x year of treatment in a sample of 94 Type 2 diabetic patients referred for insulin therapy to an outpatient department (OPD). Treatment was aimed at achieving acceptable glycaemic control by means of maximizing oral therapy, if necessary switching over to insulin therapy, and information and education provided by a diabetes specialist nurse and dietitian. Methods: QoL was measured using a disease-specific (Diabetes Health Profile (DHP)) and a generic questionnaire (RAND-36). After 1 year the medical examination and QoL measurements were repeated. The association between 1-year changes in QoL and achievement of good metabolic control (final glycosylated haemoglobin (HbA(IC)) ≤ 8%), switch to insulin therapy, and presence of hyperglycaemic complaints at baseline was analysed after adjustment for appropriate confounders. Results: After x year, mean HbA(IC) was reduced from 10.4% to 7.8%. Also QoL improved in the total group. Patients who achieved good glycaemic control after 1 year (61%) improved in a similar manner as the others. Patients switched over to insulin (65%) improved in a similar manner as the others, but at the final examination they experienced more problems with social functioning and pain. Patients with hyperglycaemic complaints at baseline (49%) improved more in QoL than those without, especially in physical functioning, vitality and health change, but at the final examination still scored lower on a majority of the DHP and RAND-36 dimensions. Conclusion: Symptoms of hyperglycaemia predict the strength of an association between improvements of glycaemic control and QoL.

Original languageEnglish
Pages (from-to)23-30
Number of pages8
JournalDiabetic Medicine
Volume16
Issue number1
DOIs
Publication statusPublished - 1999

Fingerprint

Type 2 Diabetes Mellitus
Longitudinal Studies
Quality of Life
Insulin
Health
Therapeutics
Nutritionists
Social Problems
Glycosylated Hemoglobin A
Hyperglycemia
Outpatients
Education
Pain

Keywords

  • Diabetes mellitus
  • Epidemiological research
  • Glycaemic control
  • Hyperglycaemia
  • Insulin therapy
  • Quality of life

Cite this

Goddijn, Patricia P M ; Bilo, H. J G ; Feskens, E. J M ; Groenier, K. H. ; Van der Zee, K.I. ; Meyboom-De Jong, B. / Longitudinal study on glycaemic control and quality of life in patients with Type 2 diabetes mellitus referred for intensified control. In: Diabetic Medicine. 1999 ; Vol. 16, No. 1. pp. 23-30.
@article{22e8c0e28d6c40eaab4b528a860df718,
title = "Longitudinal study on glycaemic control and quality of life in patients with Type 2 diabetes mellitus referred for intensified control",
abstract = "Aim: The aim of our study was to describe investigate and association between improved glycaemic control on quality of life(QoL) during x year of treatment in a sample of 94 Type 2 diabetic patients referred for insulin therapy to an outpatient department (OPD). Treatment was aimed at achieving acceptable glycaemic control by means of maximizing oral therapy, if necessary switching over to insulin therapy, and information and education provided by a diabetes specialist nurse and dietitian. Methods: QoL was measured using a disease-specific (Diabetes Health Profile (DHP)) and a generic questionnaire (RAND-36). After 1 year the medical examination and QoL measurements were repeated. The association between 1-year changes in QoL and achievement of good metabolic control (final glycosylated haemoglobin (HbA(IC)) ≤ 8{\%}), switch to insulin therapy, and presence of hyperglycaemic complaints at baseline was analysed after adjustment for appropriate confounders. Results: After x year, mean HbA(IC) was reduced from 10.4{\%} to 7.8{\%}. Also QoL improved in the total group. Patients who achieved good glycaemic control after 1 year (61{\%}) improved in a similar manner as the others. Patients switched over to insulin (65{\%}) improved in a similar manner as the others, but at the final examination they experienced more problems with social functioning and pain. Patients with hyperglycaemic complaints at baseline (49{\%}) improved more in QoL than those without, especially in physical functioning, vitality and health change, but at the final examination still scored lower on a majority of the DHP and RAND-36 dimensions. Conclusion: Symptoms of hyperglycaemia predict the strength of an association between improvements of glycaemic control and QoL.",
keywords = "Diabetes mellitus, Epidemiological research, Glycaemic control, Hyperglycaemia, Insulin therapy, Quality of life",
author = "Goddijn, {Patricia P M} and Bilo, {H. J G} and Feskens, {E. J M} and Groenier, {K. H.} and {Van der Zee}, K.I. and {Meyboom-De Jong}, B.",
year = "1999",
doi = "10.1046/j.1464-5491.1999.00002.x",
language = "English",
volume = "16",
pages = "23--30",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell Publishing",
number = "1",

}

Longitudinal study on glycaemic control and quality of life in patients with Type 2 diabetes mellitus referred for intensified control. / Goddijn, Patricia P M; Bilo, H. J G; Feskens, E. J M; Groenier, K. H.; Van der Zee, K.I.; Meyboom-De Jong, B.

In: Diabetic Medicine, Vol. 16, No. 1, 1999, p. 23-30.

Research output: Contribution to JournalArticleAcademicpeer-review

TY - JOUR

T1 - Longitudinal study on glycaemic control and quality of life in patients with Type 2 diabetes mellitus referred for intensified control

AU - Goddijn, Patricia P M

AU - Bilo, H. J G

AU - Feskens, E. J M

AU - Groenier, K. H.

AU - Van der Zee, K.I.

AU - Meyboom-De Jong, B.

PY - 1999

Y1 - 1999

N2 - Aim: The aim of our study was to describe investigate and association between improved glycaemic control on quality of life(QoL) during x year of treatment in a sample of 94 Type 2 diabetic patients referred for insulin therapy to an outpatient department (OPD). Treatment was aimed at achieving acceptable glycaemic control by means of maximizing oral therapy, if necessary switching over to insulin therapy, and information and education provided by a diabetes specialist nurse and dietitian. Methods: QoL was measured using a disease-specific (Diabetes Health Profile (DHP)) and a generic questionnaire (RAND-36). After 1 year the medical examination and QoL measurements were repeated. The association between 1-year changes in QoL and achievement of good metabolic control (final glycosylated haemoglobin (HbA(IC)) ≤ 8%), switch to insulin therapy, and presence of hyperglycaemic complaints at baseline was analysed after adjustment for appropriate confounders. Results: After x year, mean HbA(IC) was reduced from 10.4% to 7.8%. Also QoL improved in the total group. Patients who achieved good glycaemic control after 1 year (61%) improved in a similar manner as the others. Patients switched over to insulin (65%) improved in a similar manner as the others, but at the final examination they experienced more problems with social functioning and pain. Patients with hyperglycaemic complaints at baseline (49%) improved more in QoL than those without, especially in physical functioning, vitality and health change, but at the final examination still scored lower on a majority of the DHP and RAND-36 dimensions. Conclusion: Symptoms of hyperglycaemia predict the strength of an association between improvements of glycaemic control and QoL.

AB - Aim: The aim of our study was to describe investigate and association between improved glycaemic control on quality of life(QoL) during x year of treatment in a sample of 94 Type 2 diabetic patients referred for insulin therapy to an outpatient department (OPD). Treatment was aimed at achieving acceptable glycaemic control by means of maximizing oral therapy, if necessary switching over to insulin therapy, and information and education provided by a diabetes specialist nurse and dietitian. Methods: QoL was measured using a disease-specific (Diabetes Health Profile (DHP)) and a generic questionnaire (RAND-36). After 1 year the medical examination and QoL measurements were repeated. The association between 1-year changes in QoL and achievement of good metabolic control (final glycosylated haemoglobin (HbA(IC)) ≤ 8%), switch to insulin therapy, and presence of hyperglycaemic complaints at baseline was analysed after adjustment for appropriate confounders. Results: After x year, mean HbA(IC) was reduced from 10.4% to 7.8%. Also QoL improved in the total group. Patients who achieved good glycaemic control after 1 year (61%) improved in a similar manner as the others. Patients switched over to insulin (65%) improved in a similar manner as the others, but at the final examination they experienced more problems with social functioning and pain. Patients with hyperglycaemic complaints at baseline (49%) improved more in QoL than those without, especially in physical functioning, vitality and health change, but at the final examination still scored lower on a majority of the DHP and RAND-36 dimensions. Conclusion: Symptoms of hyperglycaemia predict the strength of an association between improvements of glycaemic control and QoL.

KW - Diabetes mellitus

KW - Epidemiological research

KW - Glycaemic control

KW - Hyperglycaemia

KW - Insulin therapy

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=0032977286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032977286&partnerID=8YFLogxK

U2 - 10.1046/j.1464-5491.1999.00002.x

DO - 10.1046/j.1464-5491.1999.00002.x

M3 - Article

VL - 16

SP - 23

EP - 30

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

IS - 1

ER -